切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2017, Vol. 06 ›› Issue (05) : 372 -377. doi: 10.3877/cma.j.issn.2095-3232.2017.05.009

所属专题: 文献

临床研究

联合肝脏离断和门静脉结扎的分阶段肝切除术治疗肝细胞癌
谌小龙1, 汪根树1,(), 杨卿1, 姜楠1, 张俊斌1, 王励1, 李慧1, 李华1, 杨扬1, 陈规划1   
  1. 1. 510630 广州,中山大学附属第三医院肝脏外科
  • 收稿日期:2017-06-23 出版日期:2017-10-10
  • 通信作者: 汪根树
  • 基金资助:
    国家自然科学基金(81372243,81570593,81370575,81370555); 广东省自然科学基金(2015A030312013); 广东省科技计划项目(2014B020228003,2014B030301041,2015B020226004); 广州市科技计划项目(2014J4100128,201400000001-3,201508020262)

Associating liver partition and portal vein ligation for staged hepatectomy in treatment of hepatocellular carcinoma

Xiaolong Chen1, Genshu Wang1,(), Qing Yang1, Nan Jiang1, Junbin Zhang1, Li Wang1, Hui Li1, Hua Li1, Yang Yang1, Guihua Chen1   

  1. 1. Department of Hepatic Surgery, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2017-06-23 Published:2017-10-10
  • Corresponding author: Genshu Wang
  • About author:
    Corresponding author: Wang Genshu, Email:
引用本文:

谌小龙, 汪根树, 杨卿, 姜楠, 张俊斌, 王励, 李慧, 李华, 杨扬, 陈规划. 联合肝脏离断和门静脉结扎的分阶段肝切除术治疗肝细胞癌[J/OL]. 中华肝脏外科手术学电子杂志, 2017, 06(05): 372-377.

Xiaolong Chen, Genshu Wang, Qing Yang, Nan Jiang, Junbin Zhang, Li Wang, Hui Li, Hua Li, Yang Yang, Guihua Chen. Associating liver partition and portal vein ligation for staged hepatectomy in treatment of hepatocellular carcinoma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2017, 06(05): 372-377.

目的

探讨联合肝脏离断和门静脉结扎的分阶段肝切除术(ALPPS)治疗肝细胞癌(肝癌)的安全性及有效性。

方法

回顾性分析2014年9月至2014年11月在中山大学附属第三医院接受ALPPS治疗的2例肝癌患者临床资料。2例患者均签署知情同意书,符合医学伦理学规定。例1男,46岁,体重(BW)51 kg,AFP>2 000 μg/L,肝功能Child-Pugh分级A级。腹部CT示肝Ⅶ/Ⅷ段巨块型肝癌,11 cm×10 cm。未来剩余肝脏体积(FRLV)378 ml,估计的标准肝脏体积(ESLV)915 ml,FRLV/ESLV 41%,未来剩余肝脏重量(FRLW) 318 g,FRLV/BW 0.62%。例2男,30岁,BW 53 kg,AFP 42 326 μg/L,肝功能Child-Pugh分级A级。腹部CT示肝中叶巨块型肝癌,11 cm×11 cm。FRLV/ESLV 31%,FRLW/BW 0.45%。第1次手术,分离结扎门静脉右支,沿镰状韧带右侧分割肝左外叶。2例患者分别于第1次术后28、14 d行肝右三叶切除术。

结果

例1第1次术后17 d FRLV为504 ml,较术前增长33%,FRLV/ESLV由术前41%提高至55%,FRLW/BW由术前0.62%提高至0.81%。例2第1次术后7 d FRLV为574 ml,较术前增长100%,FRLV/ESLV由术前31%提高至53%,FRLW/BW由术前0.45%提高至0.91%。例1和例2分别于第2次术后45、24 d顺利出院。

结论

ALPPS为FRLV不足的肝癌患者提供新的治疗选择。

Objective

To investigate the safety and efficacy of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in the treatment of hepatocellular carcinoma (HCC).

Methods

Clinical data of 2 patients with HCC who underwent ALPPS in the Third Affiliated Hospital of Sun Yat-sen University between September 2014 and November 2014 were retrospectively analyzed. The informed consents of 2 patients were obtained and the local ethical committee approval was received. Case 1 was a 46-year-old male with the body weight (BW) of 51 kg, AFP>2 000 μg/L, and the liver function was graded as Child-Pugh class A. Abdominal CT scan revealed a massive HCC of 11 cm × 10 cm in size in the Ⅶ/Ⅷ liver segments. The future remnant liver volume (FRLV) was 378 ml. The estimated standard liver volume (ESLV) was 915 ml. The FRLV/ESLV ratio was 41%. The future remnant liver weight (FRLW) was 318 g. The FRLV/BW ratio was 0.62%. Case 2 was a 30-year-old male with the BW of 53 kg, AFP 42 326 μg/L, and the liver function was graded as Child-Pugh class A. Abdominal CT scan revealed a massive HCC of 11 cm × 11 cm in size in the middle liver segment. The FRLV/ESLV ratio was 31% and the FRLW/BW ratio was 0.45%. During the first operation, the right branch of portal vein was separated and ligated. The left liver lobe was partitioned along with the right falciform ligament. Two patients underwent right hepatic trisectionectomy at 28, 14 d after the first operation.

Results

The FRLV of case 1 was 504 ml at 17 d after the first operation, and increased 33% compared with preoperative FRLV. The FRLV/ESLV increased from 41% of preoperation to 55%. The FRLW/BW increased from 0.62% of preoperation to 0.81%. The FRLV of case 2 was 574 ml at7 d after the first operation, and increased 100% compared with preoperative FRLV. The FRLV/ESLV increased from 31% of preoperation to 53%. The FRLW/BW increased from 0.45% of preoperation to 0.91%. Case 1 and 2 were successfully discharged at postoperative 45 and 24 d.

Conclusions

ALPPS offers a novel option for the treatment of HCC patients with insufficient FRLV.

图1 例1患者影像资料及术中图片
图2 例2患者影像资料及术中图片
[1]
刘允怡,刘晓欣.对"联合肝脏离断和门静脉结扎的二步肝切除术"的述评[J].中华消化外科杂志,2013,12(7):481-484.
[2]
de Santibañes E, Clavien PA. Playing play-doh to prevent postoperative liver failure:the "ALPPS" approach [J]. Ann Surg, 2012, 255(3):415-417.
[3]
李富贵,严律南,李波,等.中国成人标准肝体积评估公式的临床研究[J].四川大学学报(医学版),2009,40(2):302-306.
[4]
Chan SC, Liu CL, Lo CM, et al. Estimating liver weight of adults by body weight and gender[J]. World J Gastroenterol, 2006, 12(14):2217-2222.
[5]
Rahbari NN, Garden OJ, Padbury R, et al. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS)[J]. HPB, 2011, 13(8):528-535.
[6]
Garcea G, Ong SL, Maddern GJ. Predicting liver failure following major hepatectomy[J]. Dig Liver Dis, 2009, 41(11):798-806.
[7]
Tanaka K, Shimada H, Matsuo K, et al. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases[J]. Eur J Surg Oncol, 2007, 33(3):329-335.
[8]
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings[J]. Ann Surg, 2012, 255(3):405-414.
[9]
Simoneau E, Aljiffry M, Salman A, et al. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases[J]. HPB, 2012, 14(7):461-468.
[10]
de Santibañes E, Alvarez FA, Ardiles V. How to avoid postoperative liver failure: a novel method[J]. World J Surg, 2012, 36(1):125-128.
[11]
Alvarez FA, Ardiles V, Sanchez Claria R, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks[J]. J Gastrointest Surg, 2013, 17(4):814-821.
[12]
Vennarecci G, Laurenzi A, Levi Sandri GB, et al. The ALPPS procedure for hepatocellular carcinoma[J]. Eur J Surg Oncol, 2014, 40(8):982-988.
[13]
Schadde E, Ardiles V, Robles-Campos R, et al. Early survival and safety of ALPPS: first report of the International ALPPS Registry[J]. Ann Surg, 2014, 260(5):829-836.
[14]
苏志雷,珊巴嘎,钟翔宇,等.肝硬化肝癌患者行ALPPS的利弊分析(附3例报道)[J].中国普外基础与临床杂志,2016(1):18-21.
[15]
刘静,陈永艺,曾荣耀,等.联合肝脏离断和门静脉结扎的二步肝切除术治疗合并较重肝硬化肝癌1例[J].世界华人消化杂志,2015(6):1038-1044.
[16]
向邦德,张志明,袁卫平,等.联合肝脏离断和门静脉结扎的二步肝切除术一例并文献复习[J].中国癌症防治杂志,2015(4):264-268.
[17]
李成鹏,钱红纲,张霁,等.联合肝脏离断和门静脉结扎二步肝切除术临床应用研究(附2例报告)[J].中国实用外科杂志,2014(8):744-748.
[18]
周俭,王征,孙健,等.联合肝脏离断和门静脉结扎的二步肝切除术[J].中华消化外科杂志,2013,12(7):485-489.
[19]
郑树国,李建伟,肖乐,等.全腹腔镜联合肝脏离断和门静脉结扎的二步肝切除术治疗肝硬化肝癌[J].中华消化外科杂志,2014,13(7):502-507.
[20]
Machado MA, Makdissi FF, Surjan RC. Totally laparoscopic ALPPS is feasible and may be worthwhile[J]. Ann Surg, 2012, 256(3):e13.
[21]
Cai X, Peng S, Duan L, et al. Completely laparoscopic ALPPS using round-the-liver ligation to replace parenchymal transection for a patient with multiple right liver cancers complicated with liver cirrhosis[J]. J Laparoendosc Adv Surg Tech A, 2014, 24(12):883-886.
[22]
Hong de F, Zhang YB, Peng SY, et al. Percutaneous microwave ablation liver partition and portal vein embolization for rapid liver regeneration: a minimally invasive first step of ALPPS for hepatocellular carcinoma[J]. Ann Surg, 2016, 264(1):e1-2.
[23]
Boggi U, Napoli N, Kauffmann EF, et al. Laparoscopic microwave liver ablation and portal vein ligation: an alternative approach to the conventional ALPPS procedure in hilar cholangiocarcinoma[J]. Ann Surg Oncol, 2016, 23 (Suppl 5):884.
[24]
Petrowsky H, Györi G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? a single-center experience[J]. Ann Surg, 2015, 261(4):e90-92.
[1] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[5] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[6] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[7] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[8] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[9] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[10] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[11] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[12] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[13] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[14] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[15] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?